Literature DB >> 7852123

Base of skull and cervical spine chordomas in children treated by high-dose irradiation.

V Benk1, N J Liebsch, J E Munzenrider, J Efird, P McManus, H Suit.   

Abstract

PURPOSE: To evaluate the outcome of children with base of skull or cervical spine chordomas treated by high dose irradiation. METHODS AND MATERIALS: Eighteen children, 4 to 18 years of age, with base of skull or cervical spine chordomas, received fractionated high-dose postoperative radiation using mixed photon and 160 MeV proton beams. The median tumor dose was 69 Cobalt Gray-equivalent (CGE) with a 1.8 CGE daily fraction.
RESULTS: The median follow-up was 72 months. The 5-year actuarial survival was 68% and the 5-year disease-free survival (DFS) was 63%. The only significant prognostic factor was the location: patients with cervical spine chordomas had a worse survival than those with base of skull lesions (p = 0.008). The incidence of treatment-related morbidity was acceptable: two patients developed a growth hormone deficit corrected by hormone replacement, one temporal lobe necrosis, and one fibrosis of the temporalis muscle, improved by surgery.
CONCLUSION: Chordomas in children behave similarly to those in adults: children can receive the same high-dose irradiation as adults with acceptable morbidity.

Entities:  

Mesh:

Year:  1995        PMID: 7852123     DOI: 10.1016/0360-3016(94)00395-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

2.  Giant-cell tumors of the sphenoid bone in four children: radiological, clinical, and pathological findings.

Authors:  A L Weber; E B Hug; M W Muenter; H D Curtin
Journal:  Skull Base Surg       Date:  1997

Review 3.  Craniovertebral junction neoplasms in the pediatric population.

Authors:  Arnold H Menezes
Journal:  Childs Nerv Syst       Date:  2008-04-10       Impact factor: 1.475

Review 4.  Chordoma in children: Case-report and review of literature.

Authors:  Jean-Louis Habrand; Jean Datchary; Stéphanie Bolle; Anne Beaudré; Ludovic de Marzi; Kévin Beccaria; Dinu Stefan; Jacques Grill; Rémi Dendale
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-08

5.  Proton beam therapy (PT) in the management of CNS tumors in childhood.

Authors:  J L Habrand; H Mammar; R Ferrand; D Pontvert; P Y Bondiau; C Kalifa; J M Zucker
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

Review 6.  Proton therapy for tumors of the skull base.

Authors:  J E Munzenrider; N J Liebsch
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

7.  Proton radiation therapy for pediatric malignancies: status report.

Authors:  E B Hug; J D Slater
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

8.  Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma.

Authors:  Shuyu Hao; Hua Song; Wei Zhang; Ashlee Seldomridge; Jinkyu Jung; Amber J Giles; Marsha-Kay Hutchinson; Xiaoyu Cao; Nicole Colwell; Adrian Lita; Mioara Larion; Dragan Maric; Mones Abu-Asab; Martha Quezado; Tamalee Kramp; Kevin Camphausen; Zhengping Zhuang; Mark R Gilbert; Deric M Park
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

Review 9.  Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients.

Authors:  Muneyoshi Yasuda; Damien Bresson; Salvatore Chibbaro; Jan F Cornelius; Marc Polivka; Loic Feuvret; Masakazu Takayasu; Bernard George
Journal:  Neurosurg Rev       Date:  2011-08-24       Impact factor: 3.042

10.  Carbon-11-methionine positron emission tomography imaging of chordoma.

Authors:  Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Kenji Sagou; Mei Tian; Tetsuya Suhara; Susumu Kandatsu; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Journal:  Skeletal Radiol       Date:  2004-07-28       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.